{"version":"1.0","provider_name":"FOURNEL ADVISORY","provider_url":"https:\/\/fournel-advisory.com\/en","author_name":"Eliot Greffier","author_url":"https:\/\/fournel-advisory.com\/en\/author\/lengletremy_t0i8i26g\/","title":"CONSEIL M&amp;A BUY-SIDE - FOURNEL ADVISORY","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"n9eeP02jaz\"><a href=\"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/\">CONSEIL M&amp;A BUY-SIDE<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/embed\/#?secret=n9eeP02jaz\" width=\"600\" height=\"338\" title=\"&#8220;CONSEIL M&amp;A BUY-SIDE&#8221; &#8212; FOURNEL ADVISORY\" data-secret=\"n9eeP02jaz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>","thumbnail_url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png","thumbnail_width":730,"thumbnail_height":729,"description":"FOURNEL ADVISORY accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition, aux c\u00f4t\u00e9s de SUBSTIPHARM, d\u2019une participation conjointe majoritaire au capital de VECTANS PHARMA. Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&amp;D \u00e0 la commercialisation, via ses deux sites industriels en France [&hellip;]"}